摘要:
An aminomethylpyridyloxymethyl/benzisoxazole substituted azabicyclic compound of formula I, pharmaceutical composition comprising same, and a method of treating one or more CNS or other disorders, including concurrent treatment of disorders such as schizophrenia and depression, wherein formula I is or a pharmaceutically acceptable salt or thereof, wherein Z is wherein Y is methylene; X is oxygen; n is 0; R1 and R2 are each hydrogen or halogen; and R3 and R4 together with the nitrogen atom to which they are attached form i) a saturated non-aromatic 3 to 7 membered monocyclic ring, said ring i) being unsubstituted or substituted or substituted with one or more (C1–C4)alkyl, (C1–C4)alkoxy(C1–C4)alkyl, or hydroxy groups.
摘要:
Antibacterial 6-acylamido-2,2-dimethyl-3-(pyrimidin-4,6-dione-2-yl)-penams, intermediates therefor, including 6-amino-2,2-dimethyl-3-(pyrimidin-4,6-dione-2-yl)penam, and processes for their preparation.
摘要:
The invention relates to compounds of the formula I ##STR1## and to pharmaceutically acceptable salts thereof, wherein Z, A, Y, X.sub.1, R.sub.1, R.sub.2, and R.sub.3 are as defined herein. The invention further relates to pharmaceutical compositions containing, and to methods of using, the compounds of formula I in the treatment of those disorders that can be treated with compounds having corticotropin-releasing factor antagonistic activity. Such disorders include various stress-related conditions, such as anxiety.
摘要:
A pharmaceutical composition for treating a disorder that is treated by modulation of serotonergic neurotransmission comprising administering (7S,9aS)-cis-2-Benzo[d]isoxazol-3-yl-7-(3-pyrrolidin-1-ylmethyl-phenoxymethyl)-octahydro-pyrido-[1,2-a]pyrazine and sertraline is disclosed.
摘要:
Antibacterial 6-acylamido-2,2-dimethyl-3-(pyrimidin-4,6-dione-2-yl)penams, intermediates therefor, including 6-amino-2,2-dimethyl-3-(pyrimidin-4,6-dione-2-yl)penam, and processes for their preparation.